#Switzerland #NVIDIA #Basel #Genedata #RFD4-Proteina

Genedata Enhances AI Discovery Workflows

Genedata, a company under Danaher, has made a significant stride in biopharmaceutical R&D by integrating the new RFD4-Proteina binder design model within its AI-enabled discovery workflows. This announcement was made in Basel, Switzerland, marking a substantial advancement in the capabilities offered by Genedata's software solutions.

The incorporation of RFD4-Proteina follows its introduction at NVIDIA's GTC conference in Berlin, highlighting Genedata's position as an early ecosystem partner in the AI-driven molecular design landscape. By linking AI-generated molecular designs with scientific data and lab results, Genedata is paving the way for researchers to convert AI predictions into actionable insights.

The overall workflow begins with scientists utilizing Genedata's AI co-scientist to outline specific target characteristics and properties they need. Subsequently, NVIDIA's open protein design models come into play, generating and assessing candidate binders effectively within Genedata's ecosystem. Laboratory results are meticulously captured and linked back to their original designs, which empowers scientists to refine and prioritize future experiments.

Othmar Pfannes, Ph.D., President of Genedata, emphasized the transformative potential of AI in protein and antibody discovery. He noted that leveraging AI's full capability transcends merely having access to robust models. It requires a sophisticated approach that integrates molecular design, experimental workflows, and scientific data into a continuous cycle of learning and improvement. Genedata serves as the digital platform that unifies these elements, enabling researchers to evaluate a broader range of candidates prior to physical testing, while preserving the scientific context of each trial.

Despite the rapid advancements in generative AI enabling unprecedented design capabilities, many organizations struggle to integrate these models into their regular research workflows. Genedata addresses this challenge by providing the necessary orchestration, governance, and scientific data infrastructure to incorporate NVIDIA's BioNeMo models, including RFD4-Proteina, seamlessly into everyday discovery processes. This integration ensures that AI-generated designs maintain compliance with established workflows while ensuring traceability and scientific context across the entire discovery lifecycle.

Through Danaher’s initiative focusing on autonomous laboratories, Genedata's capabilities link AI, automation, and scientific data, forming a closed-loop system of discovery. Each experimental outcome contributes valuable insights that inform the next design cycle, facilitating perpetual learning and enhancement in scientific endeavors while keeping researchers at the helm.

About Genedata

Genedata is recognized as a leading provider of enterprise software solutions specifically designed for biopharmaceutical R&D. By transforming complex data into insightful intelligence, Genedata enables organizations to digitalize and automate extensive data workflows, supporting more than 25 years of innovation across the global biopharma landscape. Their solutions, underpinned by deep scientific and technological acumen, empower clients to make data-driven decisions that enhance their chances of success from initial discovery through development and into clinical applications.

About Danaher

Danaher is an eminent innovator in life sciences and diagnostics, committed to harnessing science and technology to bolster human health. Through a collaborative ecosystem of industry-leading businesses, Danaher addresses intricate scientific and clinical challenges, expediting the journey of innovative solutions from conception to the patient forefront. With a dedicated workforce of approximately 60,000 worldwide, Danaher is focused on delivering a substantial impact and enhancing global quality of life through continuous enhancement and operational excellence.

To find out more about Genedata and its cutting-edge solutions, visit Genedata.